Efficacy of Maternal Serum Screening in the Prenatal Detection of Fetal Chromosome Abnormalities in Japanese Women
- 9 March 2000
- journal article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 15 (2) , 112-117
- https://doi.org/10.1159/000020987
Abstract
Objective: This prospective study assesses the efficacy of maternal serum screening for use in prenatal diagnosis of fetal anomaly and chromosome imbalance in Japanese women. Methods: Maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol were measured in 1,055 singleton pregnant women between 14 and 20 weeks of gestation. A calculated risk for trisomy 21 of ≥1/299 or α-fetoprotein ≥2.5 multiples of the median was adopted as positive. Results: Three hundred and seventy-eight of the 1, 055 women screened (35.8%) were identified as positive. Sensitivity, false-positive rate, and positive predictive value in women aged Conclusions: Our results suggest that the evaluation of each serum marker, as well as of the calculated risk, was significantly important in the prenatal detection of fetal aneuploidy.Keywords
This publication has 5 references indexed in Scilit:
- Recent trends in the prevalence of Down syndrome in Japan, 1980-1997American Journal of Medical Genetics, 1999
- A Retrospective Evaluation of Maternal Serum Screening for the Detection of Fetal AneuploidyPrenatal Diagnosis, 1997
- TRIPLE MARKER SCREENING IN NATIVE JAPANESE WOMENPrenatal Diagnosis, 1996
- Chromosomal abnormality rates at amniocentesis and in live-born infantsJAMA, 1983
- Down's syndrome. Recent trends in the United StatesJAMA, 1981